Hammerschmidt W - Search Results

1

Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity.

Nückel J, Planatscher E, Mohr AW, Deichl K, Mijočević H, Feuerherd M, Wolff L, Erber J, Schneider J, Quante M, Winter C, Ruland J, Hapfelmeier A, Hammerschmidt W, Moosmann A, Protzer U, Behrends U, Mautner J. Nückel J, et al. Among authors: hammerschmidt w. Front Immunol. 2022 Sep 7;13:889836. doi: 10.3389/fimmu.2022.889836. eCollection 2022. Front Immunol. 2022. PMID: 36159804 Free PMC article.

2

The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization.

Brielmeier M, Mautner J, Laux G, Hammerschmidt W. Brielmeier M, et al. Among authors: hammerschmidt w. J Gen Virol. 1996 Nov;77 ( Pt 11):2807-18. doi: 10.1099/0022-1317-77-11-2807. J Gen Virol. 1996. PMID: 8922475

3

Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Janz A, Oezel M, Kurzeder C, Mautner J, Pich D, Kost M, Hammerschmidt W, Delecluse HJ. Janz A, et al. Among authors: hammerschmidt w. J Virol. 2000 Nov;74(21):10142-52. doi: 10.1128/jvi.74.21.10142-10152.2000. J Virol. 2000. PMID: 11024143 Free PMC article.

4

Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells.

Mautner J, Pich D, Nimmerjahn F, Milosevic S, Adhikary D, Christoph H, Witter K, Bornkamm GW, Hammerschmidt W, Behrends U. Mautner J, et al. Among authors: hammerschmidt w. Eur J Immunol. 2004 Sep;34(9):2500-9. doi: 10.1002/eji.200324794. Eur J Immunol. 2004. PMID: 15307182 Free article.

5

Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines.

Wiesner M, Zentz C, Hammer MH, Cobbold M, Kern F, Kolb HJ, Hammerschmidt W, Zeidler R, Moosmann A. Wiesner M, et al. Among authors: hammerschmidt w. Eur J Immunol. 2005 Jul;35(7):2110-21. doi: 10.1002/eji.200425936. Eur J Immunol. 2005. PMID: 15971271 Free article.

6

Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination.

Hellebrand E, Mautner J, Reisbach G, Nimmerjahn F, Hallek M, Mocikat R, Hammerschmidt W. Hellebrand E, et al. Among authors: hammerschmidt w. Gene Ther. 2006 Jan;13(2):150-62. doi: 10.1038/sj.gt.3302602. Gene Ther. 2006. PMID: 16136164

7

Activated B cells mediate efficient expansion of rare antigen-specific T cells.

Zentz C, Wiesner M, Man S, Frankenberger B, Wollenberg B, Hillemanns P, Zeidler R, Hammerschmidt W, Moosmann A. Zentz C, et al. Among authors: hammerschmidt w. Hum Immunol. 2007 Feb;68(2):75-85. doi: 10.1016/j.humimm.2006.12.004. Epub 2007 Jan 8. Hum Immunol. 2007. PMID: 17321896

8

Conditional immortalization of human B cells by CD40 ligation.

Wiesner M, Zentz C, Mayr C, Wimmer R, Hammerschmidt W, Zeidler R, Moosmann A. Wiesner M, et al. Among authors: hammerschmidt w. PLoS One. 2008 Jan 23;3(1):e1464. doi: 10.1371/journal.pone.0001464. PLoS One. 2008. PMID: 18213373 Free PMC article.

9

CMV-specific TCR-transgenic T cells for immunotherapy.

Schub A, Schuster IG, Hammerschmidt W, Moosmann A. Schub A, et al. Among authors: hammerschmidt w. J Immunol. 2009 Nov 15;183(10):6819-30. doi: 10.4049/jimmunol.0902233. Epub 2009 Oct 28. J Immunol. 2009. PMID: 19864595

10

Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus.

Iskra S, Kalla M, Delecluse HJ, Hammerschmidt W, Moosmann A. Iskra S, et al. Among authors: hammerschmidt w. J Virol. 2010 Apr;84(7):3612-23. doi: 10.1128/JVI.01400-09. Epub 2010 Jan 20. J Virol. 2010. PMID: 20089650 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page